[go: up one dir, main page]

PL3452050T3 - Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej - Google Patents

Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej

Info

Publication number
PL3452050T3
PL3452050T3 PL17792540.1T PL17792540T PL3452050T3 PL 3452050 T3 PL3452050 T3 PL 3452050T3 PL 17792540 T PL17792540 T PL 17792540T PL 3452050 T3 PL3452050 T3 PL 3452050T3
Authority
PL
Poland
Prior art keywords
hmos
treatment
composition
infectious diarrhoea
diarrhoea
Prior art date
Application number
PL17792540.1T
Other languages
English (en)
Inventor
Bruce Mcconnell
Louise Kristine VIGSNÆS
Emma ELISON
Original Assignee
Glycom A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60202765&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3452050(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US15/147,112 external-priority patent/US20160243138A1/en
Application filed by Glycom A/S filed Critical Glycom A/S
Publication of PL3452050T3 publication Critical patent/PL3452050T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
PL17792540.1T 2016-05-05 2017-05-05 Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej PL3452050T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/147,112 US20160243138A1 (en) 2014-10-29 2016-05-05 Composition comprising HMSs/HMOs and use thereof
PCT/DK2017/050145 WO2017190754A1 (en) 2016-05-05 2017-05-05 Composition comprising hmos for the treatment of non-infectious diarrhoea

Publications (1)

Publication Number Publication Date
PL3452050T3 true PL3452050T3 (pl) 2023-06-12

Family

ID=60202765

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17792540.1T PL3452050T3 (pl) 2016-05-05 2017-05-05 Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej

Country Status (5)

Country Link
EP (1) EP3452050B1 (pl)
DK (1) DK3452050T3 (pl)
ES (1) ES2938355T3 (pl)
PL (1) PL3452050T3 (pl)
WO (1) WO2017190754A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
EP3452050B1 (en) 2016-05-05 2022-11-23 Glycom A/S Composition comprising hmos for the treatment of non-infectious diarrhoea
CN111698994A (zh) * 2017-11-30 2020-09-22 格礼卡姆股份公司 治疗小麦敏感性的hmo混合物
WO2019216815A1 (en) * 2018-05-09 2019-11-14 Carbiotix Ab Method for measuring and improving gut health
BR112021011071A2 (pt) * 2018-12-19 2021-08-31 Glycom A/S Composição e método para o tratamento de seres humanos utilizando dietas com baixo teor de fodmap
US20220022515A1 (en) 2019-02-25 2022-01-27 Nutribam Bv Composition, Food Supplement and Method for Supporting and/or Improving Intestinal Health
BE1027078A9 (nl) * 2019-02-25 2020-09-28 Nutribam Bvba Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
US20230000886A1 (en) * 2019-11-27 2023-01-05 Glycom A/S MIXTURE OF HMOs
WO2022223430A1 (en) * 2021-04-19 2022-10-27 Dsm Ip Assets B.V. A composition of enzymes and human milk oligosaccharides
CN115772489A (zh) * 2022-12-23 2023-03-10 江南大学 一种能够缓解抗生素相关性腹泻的复合微生态制剂
CN117286078B (zh) * 2023-11-21 2024-02-02 四川厌氧生物科技有限责任公司 一种改善胃肠道健康的植物乳植杆菌及其应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
AU2007222375B2 (en) 2006-03-09 2012-12-20 Centre National De La Recherche Scientifique (Cnrs) Method of producing sialylated oligosaccharides
EP2405524B1 (en) 2009-03-05 2015-10-07 Nissan Motor Co., Ltd. Bipolar secondary cell and method for producing the same
EP2417143B1 (en) 2009-04-07 2016-12-21 Glycom A/S Synthesis of 2'-o-fucosyllactose
EP3241836B1 (en) 2010-02-19 2024-10-30 Glycom A/S Polymorph of a tetrasaccharide containing nacetyl-lactosamine
CA2805499A1 (en) 2010-07-16 2012-01-19 Glycom A/S Derivatization of oligosaccharides
NZ612386A (en) * 2010-12-31 2015-02-27 Abbott Lab Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
CA3167205A1 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
CA2827294A1 (en) 2011-02-21 2012-08-30 Glycom A/S Catalytic hydrogenolysis of a composition of a mixture of oligosaccharide precursors and uses thereof
JP2014510098A (ja) 2011-03-18 2014-04-24 グリコム アー／エス 新規のフコース含有炭水化物誘導体の合成
CN103703012A (zh) 2011-05-13 2014-04-02 格礼卡姆股份公司 乳糖-n-四糖的制造
PL2707380T3 (pl) 2011-05-13 2021-01-11 Glycom A/S Dywersyfikacja oligosacharydów mleka kobiecego (hmo) lub ich prekursorów
MX2013013028A (es) 2011-05-13 2013-12-02 Glycom As Metodo para generar oligosacaridos de leche humana (hmo) o precursores de los mismos.
CN113662199A (zh) 2011-08-29 2021-11-19 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
EP2760875A4 (en) 2011-09-30 2015-08-26 Glycom As SYNTHESIS OF HMO NUCLEAR STRUCTURES
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
WO2013139344A1 (en) 2012-03-20 2013-09-26 Glycom A/S Synthesis of the trisaccharide 3-o-fucosyllactose and intermediates thereof
CN104507483A (zh) * 2012-04-13 2015-04-08 波士顿学院理事会 益生元组合物及使用方法
US20150119360A1 (en) * 2012-04-23 2015-04-30 Kyoto University Composition for promoting bifidobacteria growth
EP3082828B1 (en) 2013-11-15 2022-03-02 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section
US10695358B2 (en) 2013-12-20 2020-06-30 Abbott Laboratories Oral rehydration composition with oligosaccharides
WO2015153841A1 (en) 2014-04-04 2015-10-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
US10792294B2 (en) * 2014-04-08 2020-10-06 Abbott Laboratories Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
CN107073021A (zh) * 2014-10-29 2017-08-18 格礼卡姆股份公司 合成组合物以及用于治疗肠易激综合症的方法
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
CN108348536B (zh) 2015-11-17 2021-09-24 格礼卡姆股份公司 治疗抗生素相关性并发症的合成组合物
EP3452050B1 (en) 2016-05-05 2022-11-23 Glycom A/S Composition comprising hmos for the treatment of non-infectious diarrhoea

Also Published As

Publication number Publication date
ES2938355T3 (es) 2023-04-10
EP3452050A1 (en) 2019-03-13
WO2017190754A1 (en) 2017-11-09
EP3452050B1 (en) 2022-11-23
EP3452050A4 (en) 2020-01-08
DK3452050T3 (da) 2023-02-20

Similar Documents

Publication Publication Date Title
IL264049A (en) Compounds, preparations and methods for treating the disease
PL3452050T3 (pl) Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej
HK1247202A1 (zh) 用於治療癌症的化合物
IL264156A (en) Compounds, preparations and methods for treating the disease
EP3448874A4 (en) COMPOSITIONS FOR TREATING A DISEASE
EP3448875A4 (en) COMPOSITIONS FOR TREATING A DISEASE
EP3448987A4 (en) COMPOSITIONS FOR THE TREATMENT OF DISEASES
IL253945A0 (en) kdm1a inhibitors to treat the disease
PL3261726T3 (pl) Kompozycja do leczenia trądziku
IL259996A (en) Combinations for cancer treatment
HK1256721A1 (zh) 用於治療眼部病症的化合物和組合物
ZA201902781B (en) Compositions and methods for the treatment of xerostomia
EP3344256A4 (en) COMPOSITIONS FOR THE TREATMENT OF JOINTS
PT3122349T (pt) Composições para o tratamento da autodigestão
IL249640A0 (en) Preparations for the treatment of nosebleeds
SI3302573T1 (sl) Sestavek za zdravljenje možganskih lezij
PL3484475T3 (pl) 1-Metylonikotynamid do leczenia choroby układu krążenia
SMT202400007T1 (it) Composizione per l'uso nel trattamento di alterazioni intestinali
PT3340975T (pt) Formulação para o tratamento de acne
IL267059A (en) A preparation for the treatment of osteoarthritis
IL255167A0 (en) Compounds for the treatment of cancer
PL3273997T3 (pl) Kompozycja do leczenia nieżytu nosa
PT3524255T (pt) Composição para o tratamento do acne
IL252237A0 (en) Compounds for the treatment of cancer
GB201507042D0 (en) Treatment of the symptoms of osteoarthritis